Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sulzer Inter-Op settlement

This article was originally published in The Gray Sheet

Executive Summary

Inclusion of individual lawsuits in the firm's pending class-action hip recall settlement will be facilitated by a Cleveland federal court's reversal of an earlier California court decision, Sulzer says. The California decision overturned an earlier injunction against single-patient cases relating to the recalled hip shells and withdrawn tibial baseplates. Sulzer says it expects approval of a $783 mil. class action settlement in the spring of 2002. Plaintiffs will have from the first week in January until March 5, 2002 to opt out of the settlement (1"The Gray Sheet" Sept. 24, 2001, p. 17)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel